Concepedia

Wooseok Han

WH

14

Publications

733

Citations

14

H-Index

2002

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

University of Toronto

Novartis Institutes for BioMedical Research

Wooseok Han is an author at Novartis (Switzerland) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Top concepts

Publications per year

2002–2020

14

Publications

14

Divergent Selectivity in MgI<sub>2</sub>-Mediated Ring Expansions of Methylenecyclopropyl Amides and Imides

Mark Lautens, Wooseok Han · Journal of the American Chemical Society · 2002 · 124 citations

Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers

Pablo D. García, John L. Langowski, Yingyun Wang et al. · Clinical Cancer Research · 2014 · 110 citations · Full text

MgI<sub>2</sub>-Mediated Ring Expansions of Secondary Methylenecyclopropyl Amides

Mark Lautens, Wooseok Han, Jack Hung‐Chang Liu · Journal of the American Chemical Society · 2003 · 84 citations

, , +12

Identification of <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies

Matthew T. Burger, Gisele Nishiguchi, Wooseok Han et al. · Journal of Medicinal Chemistry · 2015 · 72 citations · Full text

, , +14

Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases

Gisele Nishiguchi, Gordana Atallah, Cornelia Bellamacina et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 62 citations · Full text

, , +6

Rows per page

1–5 of 14